Takeda Ventures

Takeda Ventures investment thesis

Takeda Ventures, Inc. is the corporate venture capital group of Takeda, and was founded in 2001 with the vision of generating disruptive technologies and therapeutic solutions for patients through venture-based investments. Takeda Ventures focuses on high-caliber, therapeutic, platform-based companies around the world. We specifically invest in early-stage, preclinical opportunities and products which complement Takeda’s pipeline with the mission to create strategic growth opportunities for Takeda through building, managing and investing in innovative companies. Takeda Ventures partners with academic innovators, entrepreneurs and venture investors to create and nurture a portfolio of companies in areas aligned with Takeda’s R&D pillars: Oncology, Rare Genetics & Hematology, Neuroscience an

Takeda Ventures team (3)

Partners and principals at Takeda Ventures:

• Miles Gerson — sweet spot $2.5M
• Michael Martin — sweet spot $2.5M
• Victor Stone — sweet spot $2.5M

Is Takeda Ventures a fit for your round?

Upload your pitch deck and see whether anyone at Takeda Ventures appears in your top matches.